Common targets in targeted therapy include growth factor receptors, proteins involved in cell signaling pathways, and genes that are mutated in cancer cells. Examples include HER2 in breast cancer, EGFR in non-small cell lung cancer, and BRAF in melanoma. These targets are identified through histological and molecular analyses of tumor samples.
